180 related articles for article (PubMed ID: 25713334)
1. Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study.
Butler LM; Huang JY; Wang R; Lee MJ; Yang CS; Gao YT; Yuan JM
Am J Epidemiol; 2015 Mar; 181(6):397-405. PubMed ID: 25713334
[TBL] [Abstract][Full Text] [Related]
2. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study.
Yuan JM; Gao YT; Yang CS; Yu MC
Int J Cancer; 2007 Mar; 120(6):1344-50. PubMed ID: 17149697
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma and urinary concentrations of green tea catechins associated with improved plasma lipid profile in healthy Japanese women.
Takechi R; Alfonso H; Hiramatsu N; Ishisaka A; Tanaka A; Tan L; Lee AH
Nutr Res; 2016 Mar; 36(3):220-6. PubMed ID: 26923508
[TBL] [Abstract][Full Text] [Related]
4. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.
Yu MW; Hsieh HH; Pan WH; Yang CS; CHen CJ
Cancer Res; 1995 Mar; 55(6):1301-5. PubMed ID: 7882326
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
[TBL] [Abstract][Full Text] [Related]
6. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
7. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma.
Yuan JM; Grouls M; Carmella SG; Wang R; Heskin A; Jiang Y; Tan YT; Adams-Haduch J; Gao YT; Hecht SS
Carcinogenesis; 2019 Aug; 40(8):989-997. PubMed ID: 30615102
[TBL] [Abstract][Full Text] [Related]
9. Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.
Muñoz A; Chen JG; Egner PA; Marshall ML; Johnson JL; Schneider MF; Lu JH; Zhu YR; Wang JB; Chen TY; Kensler TW; Groopman JD
Carcinogenesis; 2011 Jun; 32(6):860-5. PubMed ID: 21474708
[TBL] [Abstract][Full Text] [Related]
10. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial.
Brown AL; Lane J; Holyoak C; Nicol B; Mayes AE; Dadd T
Br J Nutr; 2011 Dec; 106(12):1880-9. PubMed ID: 21736785
[TBL] [Abstract][Full Text] [Related]
11. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
[TBL] [Abstract][Full Text] [Related]
12. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers.
Yang CS; Chen L; Lee MJ; Balentine D; Kuo MC; Schantz SP
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):351-4. PubMed ID: 9568793
[TBL] [Abstract][Full Text] [Related]
13. Catechins are bioavailable in men and women drinking black tea throughout the day.
Warden BA; Smith LS; Beecher GR; Balentine DA; Clevidence BA
J Nutr; 2001 Jun; 131(6):1731-7. PubMed ID: 11385060
[TBL] [Abstract][Full Text] [Related]
14. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.
Loomba R; Yang HI; Su J; Brenner D; Barrett-Connor E; Iloeje U; Chen CJ
Am J Epidemiol; 2013 Feb; 177(4):333-42. PubMed ID: 23355498
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of infection with hepatitis G virus in relation to hepatocellular carcinoma in Shanghai, China.
Yuan JM; Govindarajan S; Gao YT; Ross RK; Yu MC
J Infect Dis; 2000 Nov; 182(5):1300-3. PubMed ID: 11023453
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
17. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort.
Welzel TM; Katki HA; Sakoda LC; Evans AA; London WT; Chen G; O'Broin S; Shen FM; Lin WY; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1279-82. PubMed ID: 17548697
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
Lee MJ; Maliakal P; Chen L; Meng X; Bondoc FY; Prabhu S; Lambert G; Mohr S; Yang CS
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1025-32. PubMed ID: 12376503
[TBL] [Abstract][Full Text] [Related]
19. Determination of catechins in human urine subsequent to tea ingestion by high-performance liquid chromatography with electrochemical detection.
Yang B; Arai K; Kusu F
Anal Biochem; 2000 Jul; 283(1):77-82. PubMed ID: 10929811
[TBL] [Abstract][Full Text] [Related]
20. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.
Bamia C; Lagiou P; Jenab M; Trichopoulou A; Fedirko V; Aleksandrova K; Pischon T; Overvad K; Olsen A; Tjønneland A; Boutron-Ruault MC; Fagherazzi G; Racine A; Kuhn T; Boeing H; Floegel A; Benetou V; Palli D; Grioni S; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Dik VK; Bhoo-Pathy N; Uiterwaal CS; Weiderpass E; Lund E; Quirós JR; Zamora-Ros R; Molina-Montes E; Chirlaque MD; Ardanaz E; Dorronsoro M; Lindkvist B; Wallström P; Nilsson LM; Sund M; Khaw KT; Wareham N; Bradbury KE; Travis RC; Ferrari P; Duarte-Salles T; Stepien M; Gunter M; Murphy N; Riboli E; Trichopoulos D
Int J Cancer; 2015 Apr; 136(8):1899-908. PubMed ID: 25219573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
